表紙
市場調查報告書

急性胰炎的全球市場:∼2025年

Global Acute Pancreatitis Market Research Report - Forecast till 2025

出版商 Market Research Future 商品編碼 926860
出版日期 內容資訊 英文 116 Pages
訂單完成後即時交付
價格
急性胰炎的全球市場:∼2025年 Global Acute Pancreatitis Market Research Report - Forecast till 2025
出版日期: 2019年12月01日內容資訊: 英文 116 Pages
簡介

全球急性胰炎的市場,由於膽囊結石的增加,酒精消費量的增加等要素而受推進,根據FDA的嚴格法規而停止進一步成長。可是大醫藥品經營者的穩定開發平台創造很大的成長機會。各地區中,由於急性胰炎的盛行率擴大,膽囊結石患者人口,酒精消費量多等要素,北美地區預計記錄最大的佔有率。該市場由於先進且有效的診斷試驗及治療選擇的需求高漲,使市場成長。同時,在預測期間內的成長率預計亞太地區記錄最高的成長率。據信這是由於中國、印度、韓國等新興各國成為臨床試驗,醫藥品製造,病理檢驗的主要外包處等。

本報告提供全球急性胰炎的市場調查,市場定義和概要,對市場成長的各種影響因素及市場機會分析,價值鏈,流行病學資料,相關法律,開發平台分析,各原因、治療/診斷區分、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等資訊彙整。

第1章 摘要整理

第2章 簡介

第3章 調查方法

第4章 市場動態

  • 概要
  • 成長推動因素
  • 阻礙成長要素
  • 市場機會

第5章 市場影響因素分析

  • 波特的五力分析
  • 價值鏈分析
  • 流行病學資料
  • 法規方案
  • 開發平台分析

第6章 急性胰炎市場分析、預測:各原因

  • 概要
  • 膽囊結石
  • 酒精
  • 其他原因

第7章 急性胰炎市場分析、預測:各治療/診斷種類

  • 概要
  • 治療
  • 診斷

第8章 急性胰炎市場分析、預測:各終端用戶

  • 概要
  • 醫院、診所
  • 其他

第9章 急性胰炎市場分析、預測:各地區、主要國家

  • 概要
  • 南北美洲
  • 歐洲
  • 亞太地區
  • 中東、非洲地區

第10章 競爭環境

第11章 公司概要

  • CALCIMEDICA
  • SCM LIFESCIENCE
  • SAMSUNG BIOEPIS
  • GNT PHARMA CO., LTD
  • BAXTER INTERNATIONAL INC.
  • B. BRAUN MELSUNGEN AG
  • GENERAL ELECTRIC COMPANY
  • MEDTRONIC
  • BOSTON SCIENTIFIC CORPORATION
  • FRESENIUS KABI USA

第12章 附錄

目錄

Title:
Global Acute Pancreatitis Market:
FoData segmented by Cause, Treatment & Diagnosis, End User and Region - Forecast to 2025.

Market Analysis

Acute pancreatitis is a condition where the pancreas becomes inflamed. The most common cause of acute pancreatitis is stones in the gallbladder. There are several other reasons, such as heavy alcohol consumption, ingested medicines, and others that cause acute pancreatitis. The rising prevalence of gallstones and high consumption of alcohol is driving the global acute pancreatitis market. However, stringent regulations imposed by the FDA (Food and Drug Administration) is expected to hamper the growth of this market. The robust pipeline by significant manufacturers operating in the market is creating lucrative opportunities for the growth of the market.

Market segmentation

The acute pancreatitis market, based on cause is segmented into gallstones, alcohol and other causes. The acute pancreatitis markets, based on treatment & diagnosis, have been segmented into the treatment and diagnosis. Based on end user, the market is segmented into hospitals & clinics and others.

Regional analysis

Based on region the global acute pancreatitis market is divided up into the Americas, Europe, Asia-Pacific, and also the Middle East and Africa. The global acute pancreatitis market in the Americas has been segmented into North America and Latin America. North America is expected to dominate the market, mainly due to the increasing prevalence of acute pancreatitis, huge number of population suffering from gall stones and high consumption of alcohol among the population in the region. The increasing incidence of acute pancreatitis has led to a rise in the demand for advanced and effective diagnostic tests and treatment options resulting in the market growth.

Europe accounts for the second-largest market share in the global acute pancreatitis market. The European market is divided into Western Europe and Eastern Europe. There is an increase in market growth in this region owing to the adaption of sedentary lifestyle, people have high cholesterol level and lack of physical activities.

Asia-Pacific is expected to be the fastest-growing market for acute pancreatitis during the forecast period. This can be attributed to developing economies such as China, India, and South Korea emerging as major destinations for the outsourcing of clinical trials, drug manufacturing, and pathology testing. The Middle East & Africa is expected to have limited market growth due to the lack of proper healthcare facilities. However, countries such as Kuwait, the UAE, and Saudi Arabia are likely to show steady growth due to increasing obesity issues, rising initiatives by governments to improve patient care, and favorable reimbursement policies.

Major players

Development of news product, innovation, and strategic collaboration are few crucial techniques followed by the global players operating in the acute pancreatitis market. The major key players in the global acute pancreatitis market are- Baxter International Inc. (US), CalciMedica(US), Fresenius Kabi USA(US) , SCM Lifescience (South Korea), Samsung Bioepis (South Korea), GNT Pharma Co., Ltd (South Korea), B. Braun Melsungen AG(Germany), General Electric Company (US), Medtronic (Ireland), Boston Scientific Corporation (US)as well as others.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW 14
    • 1.1.1 MARKET SYNOPSIS 14

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY 15
  • 2.2 RESEARCH OBJECTIVE 15
  • 2.3 LIST OF ASSUMPTIONS 15

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW 17
  • 3.2 DATA MINING 17
  • 3.3 SECONDARY RESEARCH 18
  • 3.4 PRIMARY RESEARCH 18
    • 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19
    • 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 19
  • 3.5 FORECASTING TECHNIQUES 20
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
    • 3.6.1 BOTTOM-UP APPROACH 21
    • 3.6.2 TOP-DOWN APPROACH 22
  • 3.7 DATA TRIANGULATION 22
  • 3.8 VALIDATION 23

4 MARKET DYNAMICS

  • 4.1 OVERVIEW 24
  • 4.2 DRIVERS 25
    • 4.2.1 RISING PREVALENCE OF GALLSTONES 25
    • 4.2.2 HIGH CONSUMPTION OF ALCOHOL 25
  • 4.3 RESTRAINTS 26
    • 4.3.1 STRINGENT REGULATORY STANDARDS OF THE FOOD DRUG AND ADMINISTRATION 26
  • 4.4 OPPORTUNITIES 26
    • 4.4.1 STRONG PIPELINE 26

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL 27
    • 5.1.1 THREAT OF NEW ENTRANTS 27
    • 5.1.2 BARGAINING POWER OF SUPPLIERS 28
    • 5.1.3 THREAT OF SUBSTITUTES 28
    • 5.1.4 BARGAINING POWER OF BUYERS 28
    • 5.1.5 INTENSITY OF RIVALRY 28
  • 5.2 VALUE CHAIN ANALYSIS 29
    • 5.2.1 R&D AND DESIGNING 30
    • 5.2.2 MANUFACTURING 30
    • 5.2.3 DISTRIBUTION 30
    • 5.2.4 MARKETING & SALES 30
    • 5.2.5 POST-SALES MONITORING 30
  • 5.3 EPIDEMIOLOGY DATA 31
  • 5.4 REGULATORY SCENARIO 31
  • 5.5 PIPELINE ANALYSIS 31

6 GLOBAL ACUTE PANCREATITIS, BY CAUSE

  • 6.1 OVERVIEW 34
  • 6.2 GALLSTONES 35
  • 6.3 ALCOHOL 36
  • 6.4 OTHER CAUSES 36

7 GLOBAL ACUTE PANCREATITIS, BY TREATMENT & DIAGNOSIS

  • 7.1 OVERVIEW 37
  • 7.2 TREATMENT 39
  • 7.3 DIAGNOSIS 39

8 GLOBAL ACUTE PANCREATITIS, BY END USER

  • 8.1 OVERVIEW 41
  • 8.2 HOSPIATLS & CLINICS 42
  • 8.3 OTHERS 42

9 GLOBAL ACUTE PANCREATITIS, BY REGION

  • 9.1 OVERVIEW 43
  • 9.2 AMERICAS 45
    • 9.2.1 NORTH AMERICA 47
    • 9.2.2 LATIN AMERICA 52
  • 9.3 EUROPE 54
    • 9.3.1 WESTERN EUROPE 56
    • 9.3.2 EASTERN EUROPE 67
  • 9.4 ASIA-PACIFIC 70
    • 9.4.1 JAPAN 72
    • 9.4.2 CHINA 74
    • 9.4.3 INDIA 75
    • 9.4.4 AUSTRALIA 77
    • 9.4.5 SOUTH KOREA 78
    • 9.4.6 REST OF ASIA-PACIFIC 80
  • 9.5 MIDDLE EAST & AFRICA 82
    • 9.5.1 MIDDLE EAST 84
    • 9.5.2 AFRICA 86

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW 88

11 COMPANY PROFILES

  • 11.1 CALCIMEDICA 89
    • 11.1.1 COMPANY OVERVIEW 89
    • 11.1.2 FINANCIAL OVERVIEW 89
    • 11.1.3 PRODUCTS/SERVICES OFFERED 89
    • 11.1.4 KEY DEVELOPMENTS 89
    • 11.1.5 SWOT ANALYSIS 90
    • 11.1.6 KEY STRATEGIES 90
  • 11.2 SCM LIFESCIENCE 91
    • 11.2.1 COMPANY OVERVIEW 91
    • 11.2.2 FINANCIAL OVERVIEW 91
    • 11.2.3 PRODUCTS/SERVICES OFFERED 91
    • 11.2.4 KEY DEVELOPMENTS 91
    • 11.2.5 SWOT ANALYSIS 92
    • 11.2.6 KEY STRATEGIES 92
  • 11.3 SAMSUNG BIOEPIS 93
    • 11.3.1 COMPANY OVERVIEW 93
    • 11.3.2 FINANCIAL OVERVIEW 93
    • 11.3.3 PRODUCTS/SERVICES OFFERED 93
    • 11.3.4 KEY DEVELOPMENTS 93
    • 11.3.5 SWOT ANALYSIS 94
    • 11.3.6 KEY STRATEGIES 94
  • 11.4 GNT PHARMA CO., LTD 95
    • 11.4.1 COMPANY OVERVIEW 95
    • 11.4.2 FINANCIAL OVERVIEW 95
    • 11.4.3 PRODUCTS/SERVICES OFFERED 95
    • 11.4.4 KEY DEVELOPMENTS 95
    • 11.4.5 SWOT ANALYSIS 96
    • 11.4.6 KEY STRATEGIES 96
  • 11.5 BAXTER INTERNATIONAL INC. 97
    • 11.5.1 COMPANY OVERVIEW 97
    • 11.5.2 FINANCIAL OVERVIEW 97
    • 11.5.3 PRODUCTS/SERVICES OFFERED 98
    • 11.5.4 KEY DEVELOPMENTS 98
    • 11.5.5 SWOT ANALYSIS 99
    • 11.5.6 KEY STRATEGIES 99
  • 11.6 B. BRAUN MELSUNGEN AG 100
    • 11.6.1 COMPANY OVERVIEW 100
    • 11.6.2 FINANCIAL OVERVIEW 101
    • 11.6.3 PRODUCTS/SERVICES OFFERED 101
    • 11.6.4 KEY DEVELOPMENTS 102
    • 11.6.5 SWOT ANALYSIS 102
    • 11.6.6 KEY STRATEGIES 102
  • 11.7 GENERAL ELECTRIC COMPANY 103
    • 11.7.1 COMPANY OVERVIEW 103
    • 11.7.2 FINANCIAL OVERVIEW 103
    • 11.7.3 PRODUCTS/SERVICES OFFERED 104
    • 11.7.4 KEY DEVELOPMENTS 104
    • 11.7.5 SWOT ANALYSIS 105
    • 11.7.6 KEY STRATEGIES 105
  • 11.8 MEDTRONIC 106
    • 11.8.1 COMPANY OVERVIEW 106
    • 11.8.2 FINANCIAL OVERVIEW 106
    • 11.8.3 PRODUCTS/SERVICES OFFERED 107
    • 11.8.4 KEY DEVELOPMENTS 107
    • 11.8.5 SWOT ANALYSIS 107
    • 11.8.6 KEY STRATEGIES 108
  • 11.9 BOSTON SCIENTIFIC CORPORATION 109
    • 11.9.1 COMPANY OVERVIEW 109
    • 11.9.2 FINANCIAL OVERVIEW 109
    • 11.9.3 PRODUCTS/SERVICES OFFERED 110
    • 11.9.4 KEY DEVELOPMENTS 110
    • 11.9.5 SWOT ANALYSIS 110
    • 11.9.6 KEY STRATEGIES 111
  • 11.10 FRESENIUS KABI USA 112
    • 11.10.1 COMPANY OVERVIEW 112
    • 11.10.2 FINANCIAL OVERVIEW 112
    • 11.10.3 PRODUCTS/SERVICES OFFERED 113
    • 11.10.4 KEY DEVELOPMENTS 113
    • 11.10.5 SWOT ANALYSIS 114
    • 11.10.6 KEY STRATEGIES 114

12 APPENDIX

  • 12.1 REFERENCES 115
  • 12.2 RELATED REPORTS 115

List of Tables

  • TABLE 1 LIST OF ASSUMPTIONS 15
  • TABLE 2 PRODUCT PIPELINE 32
  • TABLE 3 GLOBAL ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 35
  • TABLE 4 GLOBAL ACUTE PANCREATITIS MARKET FOR GALLSTONES, BY REGION, 2016-2025 (USD MILLION) 35
  • TABLE 5 GLOBAL ACUTE PANCREATITIS MARKET FOR ALCOHOL, BY REGION, 2016-2025 (USD MILLION) 36
  • TABLE 6 GLOBAL ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 38
  • TABLE 7 GLOBAL ACUTE PANCREATITIS MARKET FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 39
  • TABLE 8 GLOBAL ACUTE PANCREATITIS MARKET FOR TREATMENT, BY REGION, 2016-2025 (USD MILLION) 39
  • TABLE 9 GLOBAL ACUTE PANCREATITIS MARKET FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 39
  • TABLE 10 GLOBAL ACUTE PANCREATITIS MARKET FOR DIAGNOSIS, BY REGION, 2016-2025 (USD MILLION) 40
  • TABLE 11 GLOBAL ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 41
  • TABLE 12 GLOBAL ACUTE PANCREATITIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2016-2025 (USD MILLION) 42
  • TABLE 13 GLOBAL ACUTE PANCREATITIS MARKET, BY REGION, 2016-2025 (USD MILLION) 44
  • TABLE 14 AMERICAS: ACUTE PANCREATITIS MARKET, BY REGION, 2016-2025 (USD MILLION) 45
  • TABLE 15 AMERICAS: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 45
  • TABLE 16 AMERICAS: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 46
  • TABLE 17 AMERICAS: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 46
  • TABLE 18 AMERICAS: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 46
  • TABLE 19 AMERICAS: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 47
  • TABLE 20 NORTH AMERICA: ACUTE PANCREATITIS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 47
  • TABLE 21 NORTH AMERICA: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 47
  • TABLE 22 NORTH AMERICA: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 48
  • TABLE 23 NORTH AMERICA: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 48
  • TABLE 24 NORTH AMERICA: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 48
  • TABLE 25 NORTH AMERICA: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 49
  • TABLE 26 US: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 49
  • TABLE 27 US: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 49
  • TABLE 28 US: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 50
  • TABLE 29 US: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 50
  • TABLE 30 US: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 50
  • TABLE 31 CANADA: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 51
  • TABLE 32 CANADA: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 51
  • TABLE 33 CANADA: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 51
  • TABLE 34 CANADA: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 52
  • TABLE 35 CANADA: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 52
  • TABLE 36 LATIN AMERICA: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 52
  • TABLE 37 LATIN AMERICA: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 52
  • TABLE 38 LATIN AMERICA: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 53
  • TABLE 39 LATIN AMERICA: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 53
  • TABLE 40 LATIN AMERICA: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 53
  • TABLE 41 EUROPE: ACUTE PANCREATITIS MARKET, BY REGION, 2016-2025 (USD MILLION) 54
  • TABLE 42 EUROPE: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 54
  • TABLE 43 EUROPE: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 55
  • TABLE 44 EUROPE: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 55
  • TABLE 45 EUROPE: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 55
  • TABLE 46 EUROPE: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 56
  • TABLE 47 WESTERN EUROPE: ACUTE PANCREATITIS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 56
  • TABLE 48 WESTERN EUROPE: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 56
  • TABLE 49 WESTERN EUROPE: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 57
  • TABLE 50 WESTERN EUROPE: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 57
  • TABLE 51 WESTERN EUROPE: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 57
  • TABLE 52 WESTERN EUROPE: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 58
  • TABLE 53 GERMANY: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 58
  • TABLE 54 GERMANY: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 58
  • TABLE 55 GERMANY: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 59
  • TABLE 56 GERMANY: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 59
  • TABLE 57 GERMANY: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 59
  • TABLE 58 FRANCE: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 60
  • TABLE 59 FRANCE: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 60
  • TABLE 60 FRANCE: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 60
  • TABLE 61 FRANCE: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 61
  • TABLE 62 FRANCE: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 61
  • TABLE 63 UK: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 61
  • TABLE 64 UK: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 61
  • TABLE 65 UK: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 62
  • TABLE 66 UK: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 62
  • TABLE 67 UK: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 62
  • TABLE 68 ITALY: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 63
  • TABLE 69 ITALY: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 63
  • TABLE 70 ITALY: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 63
  • TABLE 71 ITALY: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 64
  • TABLE 72 ITALY: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 64
  • TABLE 73 SPAIN: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 64
  • TABLE 74 SPAIN: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 64
  • TABLE 75 SPAIN: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 65
  • TABLE 76 SPAIN: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 65
  • TABLE 77 SPAIN: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 65
  • TABLE 78 REST OF WESTERN EUROPE: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 66
  • TABLE 79 REST OF WESTERN EUROPE: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 66
  • TABLE 80 REST OF WESTERN EUROPE: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 66
  • TABLE 81 REST OF WESTERN EUROPE: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 67
  • TABLE 82 REST OF WESTERN EUROPE: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 67
  • TABLE 83 EASTERN EUROPE: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 67
  • TABLE 84 EASTERN EUROPE: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 68
  • TABLE 85 EASTERN EUROPE: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 68
  • TABLE 86 EASTERN EUROPE: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 68
  • TABLE 87 EASTERN EUROPE: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 69
  • TABLE 88 ASIA-PACIFIC: ACUTE PANCREATITIS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 70
  • TABLE 89 ASIA-PACIFIC: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 70
  • TABLE 90 ASIA-PACIFIC: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 71
  • TABLE 91 ASIA-PACIFIC: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 71
  • TABLE 92 ASIA-PACIFIC: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 71
  • TABLE 93 ASIA-PACIFIC: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 72
  • TABLE 94 JAPAN: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 72
  • TABLE 95 JAPAN: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 72
  • TABLE 96 JAPAN: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 73
  • TABLE 97 JAPAN: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 73
  • TABLE 98 JAPAN: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 73
  • TABLE 99 CHINA: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 74
  • TABLE 100 CHINA: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 74
  • TABLE 101 CHINA: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 74
  • TABLE 102 CHINA: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 75
  • TABLE 103 CHINA: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 75
  • TABLE 104 INDIA: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 75
  • TABLE 105 INDIA: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 75
  • TABLE 106 INDIA: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 76
  • TABLE 107 INDIA: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 76
  • TABLE 108 INDIA: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 76
  • TABLE 109 AUSTRALIA: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 77
  • TABLE 110 AUSTRALIA: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 77
  • TABLE 111 AUSTRALIA: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 77
  • TABLE 112 AUSTRALIA: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 78
  • TABLE 113 AUSTRALIA: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 78
  • TABLE 114 SOUTH KOREA: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 78
  • TABLE 115 SOUTH KOREA: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 78
  • TABLE 116 SOUTH KOREA: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 79
  • TABLE 117 SOUTH KOREA: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 79
  • TABLE 118 SOUTH KOREA: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 79
  • TABLE 119 REST OF ASIA-PACIFIC: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 80
  • TABLE 120 REST OF ASIA-PACIFIC: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 80
  • TABLE 121 REST OF ASIA-PACIFIC: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 80
  • TABLE 122 REST OF ASIA-PACIFIC: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 81
  • TABLE 123 REST OF ASIA-PACIFIC: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 81
  • TABLE 124 MIDDLE EAST & AFRICA: ACUTE PANCREATITIS MARKET, BY REGION, 2016-2025 (USD MILLION) 82
  • TABLE 125 MIDDLE EAST & AFRICA: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 82
  • TABLE 126 MIDDLE EAST & AFRICA: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 83
  • TABLE 127 MIDDLE EAST & AFRICA: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 83
  • TABLE 128 MIDDLE EAST & AFRICA: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 83
  • TABLE 129 MIDDLE EAST & AFRICA: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 84
  • TABLE 130 MIDDLE EAST: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 84
  • TABLE 131 MIDDLE EAST: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 84
  • TABLE 132 MIDDLE EAST: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 85
  • TABLE 133 MIDDLE EAST: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 85
  • TABLE 134 MIDDLE EAST: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 85
  • TABLE 135 AFRICA: ACUTE PANCREATITIS MARKET, BY CAUSE, 2016-2025 (USD MILLION) 86
  • TABLE 136 AFRICA: ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2016-2025 (USD MILLION) 86
  • TABLE 137 AFRICA: ACUTE PANCREATITIS MARKET, FOR TREATMENT, BY TYPE, 2016-2025 (USD MILLION) 86
  • TABLE 138 AFRICA: ACUTE PANCREATITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2016-2025 (USD MILLION) 87
  • TABLE 139 AFRICA: ACUTE PANCREATITIS MARKET, BY END USER, 2016-2025 (USD MILLION) 87
  • TABLE 140 CALCIMEDICA PRODUCTS/SERVICES OFFERED 89
  • TABLE 141 CALCIMEDICA: KEY DEVELOPMENTS 89
  • TABLE 142 SCM LIFESCIENCE PRODUCTS/SERVICES OFFERED 91
  • TABLE 143 SCM LIFESCIENCE: KEY DEVELOPMENTS 91
  • TABLE 144 TAKEDA PHARMACEUTICAL COMPANY LIMITED PRODUCTS/SERVICES OFFERED 93
  • TABLE 145 SAMSUNG BIOEPIS: KEY DEVELOPMENTS 93
  • TABLE 146 GNT PHARMA CO., LTD PRODUCTS/SERVICES OFFERED 95
  • TABLE 147 BAXTER INTERNATIONAL INC.: PRODUCTS/SERVICES OFFERED 98
  • TABLE 148 BAXTER INTERNATIONAL INC.: KEY DEVELOPMENTS 98
  • TABLE 149 B. BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED 101
  • TABLE 150 GENERAL ELECTRIC COMPANY: PRODUCTS/SERVICES OFFERED 104
  • TABLE 151 MEDTRONIC PRODUCTS/SERVICES OFFERED 107
  • TABLE 152 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED 110
  • TABLE 153 FRESENIUS KABI USA: PRODUCTS/SERVICES OFFERED 113

List of Figures

  • FIGURE 1 GLOBAL ACUTE PANCREATITIS MARKET STRUCTURE 16
  • FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 21
  • FIGURE 3 MARKET DYNAMICS: ANALYSIS OF GLOBAL ACUTE PANCREATITIS MARKET 24
  • FIGURE 4 DRIVER IMPACT ANALYSIS 25
  • FIGURE 5 RESTRAINT IMPACT ANALYSIS 26
  • FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ACUTE PANCREATITIS MARKET 27
  • FIGURE 7 VALUE CHAIN ANALYSIS OF THE GLOBAL ACUTE PANCREATITIS MARKET 29
  • FIGURE 8 PIPELINE ANALYSIS 33
  • FIGURE 9 GLOBAL ACUTE PANCREATITIS MARKET, BY CAUSE, 2018 (% SHARE) 34
  • FIGURE 10 GLOBAL ACUTE PANCREATITIS MARKET, BY CAUSE 2018 & 2025 (USD MILLION) 35
  • FIGURE 11 GLOBAL ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS, 2018 (% SHARE) 38
  • FIGURE 12 GLOBAL ACUTE PANCREATITIS MARKET, BY TREATMENT & DIAGNOSIS 2018 & 2025 (USD MILLION) 38
  • FIGURE 13 GLOBAL ACUTE PANCREATITIS MARKET, BY END USER, 2018 (% SHARE) 41
  • FIGURE 14 GLOBAL ACUTE PANCREATITIS MARKET, BY END USER 2018 & 2025 (USD MILLION) 42
  • FIGURE 15 GLOBAL ACUTE PANCREATITIS MARKET, BY REGION, 2018 (% SHARE) 44
  • FIGURE 16 GLOBAL ACUTE PANCREATITIS MARKET, BY REGION, 2018 & 2025 (USD MILLION) 44
  • FIGURE 17 AMERICAS ACUTE PANCREATITIS MARKET SHARE, BY REGION 2018 (%) 45
  • FIGURE 18 EUROPE ACUTE PANCREATITIS MARKET SHARE, BY REGION 2018 (%) 54
  • FIGURE 19 ASIA-PACIFIC ACUTE PANCREATITIS MARKET SHARE, BY COUNTRY 2018 (%) 70
  • FIGURE 20 MIDDLE EAST & AFRICA: ACUTE PANCREATITIS MARKET SHARE, BY COUNTRY 2018 (%) 82
  • FIGURE 21 CALCIMEDICA: SWOT ANALYSIS 90
  • FIGURE 22 SCM LIFESCIENCE: SWOT ANALYSIS 92
  • FIGURE 23 SAMSUNG BIOEPIS: SWOT ANALYSIS 94
  • FIGURE 24 GNT PHARMA CO., LTD: SWOT ANALYSIS 96
  • FIGURE 25 BAXTER INTERNATIONAL INC.: FINANCIAL OVERVIEW SNAPSHOT 97
  • FIGURE 26 BAXTER INTERNATIONAL INC.: SWOT ANALYSIS 99
  • FIGURE 27 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT 101
  • FIGURE 28 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS 102
  • FIGURE 29 GENERAL ELECTRIC COMPANY: FINANCIAL OVERVIEW SNAPSHOT 103
  • FIGURE 30 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS 105
  • FIGURE 31 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT 106
  • FIGURE 32 MEDTRONIC: SWOT ANALYSIS 107
  • FIGURE 33 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 109
  • FIGURE 34 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS 110
  • FIGURE 35 FRESENIUS KABI USA: FINANCIAL OVERVIEW SNAPSHOT 112
  • FIGURE 36 FRESENIUS KABI USA: SWOT ANALYSIS 114